Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century.
about
Combination prevention: new hope for stopping the epidemicTransfusion of Human Platelets Treated with Mirasol Pathogen Reduction Technology Does Not Induce Acute Lung Injury in MiceMirasol pathogen reduction technology treatment of human whole blood does not induce acute lung injury in mice.Perioperative blood management strategies for patients undergoing total knee replacement: Where do we stand now?Virome Analysis of Transfusion Recipients Reveals a Novel Human Virus That Shares Genomic Features with Hepaciviruses and PegivirusesThe HIV Epidemic: High-Income Countries.Transmission of human immunodeficiency virus infection by renal transplantation.Blood transfusions and the subsequent risk of cancers in the United States elderlyDecrease in hepatitis B prevalence among blood donors in Central-West Brazil.Factors in enhancing blood safety by nucleic acid technology testing for human immunodeficiency virus, hepatitis C virus and hepatitis B virus.Complications of apheresis.Therapeutic plasma exchange: a technical and operational review.Malaria and blood transfusion: major issues of blood safety in malaria-endemic countries and strategies for mitigating the risk of Plasmodium parasites.Impact of using different blood donor subpopulations and models on the estimation of transfusion transmission residual risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in Zimbabwe.Residual risk of transmission of human immunodeficiency virus and hepatitis C virus infections by blood transfusion in northern Brazil.The characteristics of hepatitis B surface antigen (HBsAg)-negative hepatitis B virus (HBV) infection in Chinese blood donors: a follow-up study of donors tested negative for HBsAg and reactive for simultaneous nucleic acid testing of HBV, hepatitisFourth generation assays for HIV testing.Blood management protocol for total knee arthroplasty to reduce blood wastage and unnecessary transfusion.Risk factors for hepatitis B and C infection among blood donors in five Chinese blood centers.Predonation screening of candidate donors and prevention of window period donations.Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.Multinational assessment of blood-borne virus testing and transfusion safety on the African continent.An aspirin a day: the allure (and distraction) of chemoprevention.Hepatitis B and C co-infection in HIV/AIDS population in the state of Michigan.Factors that influence blood loss and need for transfusion following total knee arthroplasty.Seroepidemiological Study of Hepatitis B, C and HIV among Blood Donors in Kerman2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery.Economic evaluation of cell salvage in pediatric surgery.
P2860
Q24630559-30C4C80E-EF78-45EC-B02E-FF246FD77748Q27302578-5AC9CBC4-DED9-4641-8249-E8363B34402DQ33751938-75142F2D-9D67-4FC1-A1A7-BBE9464834EDQ33818396-59C8E359-F33E-41EC-8670-DA98B5E0D7CFQ35784419-04FF00C7-E60A-4DA5-BE72-B46ABA32EFCCQ35902684-07C1558C-EFB1-477A-BF01-3428AB6A1B7FQ36082312-0326BA81-67A1-4019-8079-EC130E7C3B82Q36787991-13143C47-091D-4EAD-B8F1-D2860EC2B9B8Q37008485-A29FF9EA-168D-4EF0-A917-4B6D37C9BE52Q37618604-6486C17D-2E4C-4D69-84B9-D0C015D4B244Q37982852-996B2AD7-AEA5-4AB2-AB0B-030AAFCA1D1CQ38082733-47457172-AFDC-4F19-9B8C-2E4853ED25A1Q38623914-488B3B98-A6D5-42B9-8888-CCFE08CD31C3Q40071178-80A763F5-5417-43FB-84EE-65B37F992ED4Q40169707-93DD0164-596A-4C52-8F91-F2F53E93D23AQ40344145-B830B518-E0E5-4EE8-A5C8-F842FC0130EFQ40707370-417747E0-1811-427C-814B-5DF81AC26A08Q41277606-C6D16149-6188-48A5-8496-6BA1DDA18F9DQ41669992-61E2A782-0A4C-4BEB-8C0E-CBDAB24D1F70Q42199551-B630EE54-B251-4ECC-A613-A1DBA7A406A3Q42981169-8962CDCB-079C-404D-AED2-D6AF2B550C17Q42982287-5D55C9E5-900F-4332-86B9-AAABB95AD98BQ44527199-3D2F09AB-F82F-4A6C-B31C-9C86D4CC9553Q45266011-FC83AF3C-C9D9-4A9F-8F21-A5049448FF1CQ47224729-CBE083A8-6529-43EB-83A5-4F1248CBAF5FQ47559783-890D181A-7072-436A-BABB-1FB33A2A347AQ50065194-9B4BBA90-220C-471D-A891-8AE8002540C7Q50487257-1E774250-31EE-45D8-8B64-33D026E75C45
P2860
Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century.
@en
Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century.
@nl
type
label
Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century.
@en
Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century.
@nl
prefLabel
Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century.
@en
Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century.
@nl
P2093
P1433
P1476
Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century.
@en
P2093
L P Fernando
P V Holland
P356
10.1111/J.1423-0410.2010.01426.X
P577
2011-01-01T00:00:00Z